Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
Authors: Wenfeng Fang, Lin Wu, Xiangjiao Meng, Yu Yao, Wei Zuo, Wenxiu Yao, Yanyan Xie, Yu Zhang, Jiuwei Cui, Yongchang Zhang, Xingya Li, Wu Zhuang, Jian Fang, Qiming Wang, Wei Jiang, Kai Li, Yuju Bai, Yongzhong Luo, Fang Ma, Yan Yu, Wei Zheng, Zhentian Liu, Bin Yang, Rui Ma, Yong Fang, Runxiang Yang, Liyan Jiang, Jie Hu, Jiacheng Yang, Yina Diao, Xiaoping Jin, Junyou Ge, Yunpeng Yang, Li Zhang
Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Central South University, Hunan Cancer Hospital, Shandong Tumor Hospital, Shandong First Medical University, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, First Affiliated Hospital of Nanchang University, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, The People's Hospital of Guangxi Zhuang Autonomous Region, Mianyang Central Hospital, First Hospital of Jilin University, First Affiliated Hospital of Zhengzhou University, Fujian Provincial Cancer Hospital, Peking University Cancer Hospital, Zhengzhou University, Henan Cancer Hospital, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Zunyi Medical University, Second Xiangya Hospital of Central South University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, China Medical University, Jiangxi Provincial Cancer Hospital, Hubei Cancer Hospital, Liaoning Cancer Hospital & Institute, Sir Run Run Shaw Hospital, Zhejiang University, Kunming Medical University, Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai Medical College of Fudan University, Fudan University, Zhongshan Hospital, Kelun Group (China)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415334747